It was reported on Tuesday that CATO SMS, a company focused on specialised clinical research solutions, has acquired United States-based Array Biostatistics.
This move is to help CATO SMS expand its full-service biostatistical consulting, analysis and programming capabilities. CATO SMS is to concentrate on building its team of senior biostaticians and statistical programmers as part of its expansion plans.
Array will continue to be led by Sandy Ferber, chief executive officer of Array. Ferber will also lead CATO SMS' overall biometrics offering.
Avidity Biosciences prices upsized common stock public offering
Sanofi's SAR402663 granted FDA fast track designation for wet AMD
Endo to share PFI and PFA data at American Orthopaedic Foot & Ankle Society Annual Meeting
Diamyd Medical secures Eurasian patent for insulin-based antigen therapy in type 1 diabetes
Sobi's Biologics License Application for NASP in uncontrolled gout accepted by FDA
Hydrosome Labs announces promising fermentation breakthrough with ultrafine bubbles
Ionis receives FDA Breakthrough Therapy designation for ION582 in Angelman syndrome
AMO Pharma signs licence agreement with PHRI and Venca Research Inc to advance new study in ARVC
Saol Therapeutics receives US FDA Complete Response Letter for SL1009 (DCA) in PDCD
Amgen and Kyowa Kirin release rocatinlimab study results in atopic dermatitis
Hemogenyx Pharmaceuticals partners with Made Scientific to advance CAR-T therapy
Lilly's Jaypirca delivers breakthrough results in front-line CLL trial